The Impact of Point-of-Care Testing for Group A Streptococcal Pharyngitis on Antibiotic Prescribing and Patient Health Outcomes in Outpatient Care: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
A recent systematic review and meta‑analysis of randomized controlled trials examined the effect of point‑of‑care (POC) testing for Group A Streptococcus (Strep A) in patients presenting with pharyngitis in outpatient settings. Across eight trials, POC testing reduced antibiotic prescribing by ~38% overall (risk ratio 0.62), and by ~41% when used as the sole intervention. This reduction occurred in both children and adults. Importantly, there were no significant differences in subsequent healthcare visits, duration of symptoms, or days missed from work or school—indicating POC testing improved antibiotic stewardship without negatively affecting patient health outcomes. Full Access: Infectious Diseases
Measles Cases Continue to Increase
As of July 22, 2025, the CDC has confirmed 1,319 measles cases reported across 40 U.S. jurisdictions, identifying 29 distinct outbreaks in 2025. Roughly 87–88% of cases (about 1,150) are linked to these outbreaks. This represents a substantial increase from 2024, when only 285 cases were reported across 33 jurisdictions. The resurgence is attributed mainly to unvaccinated populations and under-vaccinated communities, highlighting the critical need for robust MMR vaccination coverage and rapid public health response to prevent further spread. Full Access: CDC
Penicillin Allergy Assessment Pathway Versus Usual Clinical Care for Primary Care Patients With A Penicillin Allergy Record in the UK (ALABAMA): An Open-Label, Multicenter, Randomized Controlled Trial
The recent Lancet Clinical Research article, “Penicillin allergy assessment pathway versus usual clinical care”, highlights a pervasive issue: most recorded penicillin allergy labels are inaccurate. The study demonstrated that implementing a systematic allergy reassessment protocol—with patient interviews and selective testing—significantly reduced inappropriate penicillin allergy labels. This not only improves antibiotic stewardship but also lowers reliance on broader-spectrum antibiotics, leading to better patient outcomes and antibiotic use practices. Full Access: Lancet
First-Ever Guidance for Triple Elimination of Mother-to-Child Transmission of HIV, Syphilis and Hepatitis B
The World Health Organization has released the first-ever global guidance for the triple elimination of mother-to-child transmission (EMTCT) of HIV, syphilis, and hepatitis B, presented at the 13th International AIDS Society Conference in Kigali in July 2025. The guidance introduces a four‑pillar, person‑centered framework and offers actionable strategies for countries, including integrated programs and country case studies (such as Kenya and Namibia) to support elimination roadmaps and validation targets by 2030. Full Access: WHO